{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:37:42Z","timestamp":1789202262627,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014629","name":"Royal College of Physicians and Surgeons of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014629","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jmgm.2024.108939","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:33:46Z","timestamp":1736267626000},"page":"108939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In silico evaluation of bisphosphonates identifies leading candidates for SARS-CoV-2 RdRp inhibition"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5118-9005","authenticated-orcid":false,"given":"Mohammed","family":"Muzaffar-Ur-Rehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1063-2871","authenticated-orcid":false,"given":"Kishor Suryakant","family":"Chougule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-855X","authenticated-orcid":false,"given":"Ala","family":"Chandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-652X","authenticated-orcid":false,"given":"Pranali Vijaykumar","family":"Kuthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6563-3106","authenticated-orcid":false,"given":"Mohit","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3680-1577","authenticated-orcid":false,"given":"Murugesan","family":"Sankaranarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7326-3210","authenticated-orcid":false,"given":"Seshadri S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2024.108939_bib2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of postacute Sequelae of SARS-CoV-2 infection","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jmgm.2024.108939_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmgm.2024.108939_bib4","article-title":"Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 2 February 2023","year":"2023","journal-title":"ONS Website, Stat Bull"},{"key":"10.1016\/j.jmgm.2024.108939_bib5","doi-asserted-by":"crossref","first-page":"E218","DOI":"10.1503\/cmaj.220081","article-title":"Nirmatrelvir-ritonavir for COVID-19","volume":"194","author":"McDonald","year":"2022","journal-title":"C Can. Med. Assoc. J."},{"key":"10.1016\/j.jmgm.2024.108939_bib6","first-page":"18","article-title":"FDA approves first oral antiviral for treatment of COVID-19 in adults","year":"2023","journal-title":"FDA News Relea."},{"key":"10.1016\/j.jmgm.2024.108939_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2024.108939_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12879-021-06164-x","article-title":"Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis","volume":"21","author":"Manabe","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jmgm.2024.108939_bib10","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3390\/v14112417","article-title":"Use of human lung tissue models for screening of drugs against SARS-CoV-2 infection","volume":"14","author":"McAuley","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2024.108939_bib11","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2214-109X(21)00448-4","article-title":"Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial","volume":"10","author":"Reis","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jmgm.2024.108939_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2024.108939_bib13","doi-asserted-by":"crossref","first-page":"o3055","DOI":"10.1136\/bmj.o3055","article-title":"Covid-19: molnupiravir does not cut hospital admissions or deaths in vaccinated people at high risk, trial finds","volume":"379","author":"Wise","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jmgm.2024.108939_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-03667-0","article-title":"Merck's COVID pill loses its lustre: what that means for the pandemic","author":"Kozlov","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2024.108939_bib15","article-title":"Efficacy and safety of favipiravir in treating COVID-19 patients: a meta-analysis of randomized control trials","volume":"15","author":"Batool","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jmgm.2024.108939_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cmi.2021.12.026","article-title":"Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial","volume":"28","author":"Bosaeed","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jmgm.2024.108939_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2213-2600(22)00412-X","article-title":"Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care","volume":"11","author":"Shah","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jmgm.2024.108939_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijid.2023.06.018","article-title":"Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: open-label randomized controlled trial (EFFaCo study)","volume":"134","author":"Siripongboonsitti","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jmgm.2024.108939_bib19","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jmgm.2024.108939_bib20","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/bcp.15126","article-title":"Safety and efficacy of fluvoxamine in COVID\u201019 ICU patients: an open label, prospective cohort trial with matched controls","volume":"88","author":"Calusic","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jmgm.2024.108939_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/data7110164","article-title":"CoviRx: a user-friendly interface for systematic down-selection of repurposed drug candidates for COVID-19","volume":"7","author":"Jain","year":"2022","journal-title":"Data"},{"key":"10.1016\/j.jmgm.2024.108939_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911851","article-title":"Systematic down-selection of repurposed drug candidates for COVID-19","volume":"23","author":"MacRaild","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2024.108939_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1142\/S2737416523500552","article-title":"Molecular docking and dynamics identify potential drugs to be repurposed as SARS-CoV-2 inhibitors","volume":"23","author":"Muzaffar-Ur-Rehman","year":"2024","journal-title":"J. Comput. Biophys. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79548","article-title":"Association between Bisphosphonate use and COVID-19 related outcomes","volume":"12","author":"Thompson","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jmgm.2024.108939_bib25","series-title":"Use of A Nitrogen-Containing Bisphosphonate in Combination with A Glucocorticoid in Preventing or Treating Viral Pneumonia","author":"Huang","year":"2023"},{"key":"10.1016\/j.jmgm.2024.108939_bib26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2024.108939_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication\u2013transcription complexes and their relevance for SARS-CoV-2 drug design","volume":"23","author":"Malone","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmgm.2024.108939_bib28","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jiph.2022.09.007","article-title":"Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach","volume":"15","author":"Gangadharan","year":"2022","journal-title":"J. Infect. Pub. Health"},{"key":"10.1016\/j.jmgm.2024.108939_bib29","first-page":"1989","article-title":"Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: molecular docking analysis","volume":"64","author":"El Sohaimy","year":"2021","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib30","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/07391102.2021.2025147","article-title":"Molecular docking, molecular dynamics simulation and MM-GBSA studies of the activity of glycyrrhizin relevant substructures on SARS-CoV-2 RNA-dependent-RNA polymerase","volume":"41","author":"Zamzami","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2024.108939_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24695-4","article-title":"Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations","volume":"12","author":"Brunt","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2024.108939_bib32","first-page":"6","article-title":"Molecular docking and dynamics of phytochemicals from Chinese herbs with SARS-CoV-2 RdRp","volume":"17","author":"Lu","year":"2022","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.jmgm.2024.108939_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/fvl-2022-0054","article-title":"Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study","volume":"17","author":"Askari","year":"2022","journal-title":"Future Virol."},{"key":"10.1016\/j.jmgm.2024.108939_bib34","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.csbj.2022.02.001","article-title":"Identification of novel SARS-CoV-2 RNA dependent RNA polymerase (RdRp) inhibitors: from in silico screening to experimentally validated inhibitory activity","volume":"20","author":"Uengwetwanit","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jmgm.2024.108939_bib35","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1080\/07391102.2022.2154844","article-title":"Dynamics and binding affinity of nucleoside and non-nucleoside inhibitors with RdRp of SARS-CoV-2: a molecular screening, docking, and molecular dynamics simulation study","volume":"41","author":"Chinnamadhu","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2024.108939_bib36","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1080\/07391102.2022.2072392","article-title":"25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M pro and RdRp\u2013: an insight from molecular docking and dynamics simulation approaches","volume":"41","author":"Alzahrani","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2024.108939_bib37","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3389\/fmicb.2020.01796","article-title":"Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in silico analysis","volume":"11","author":"Alexpandi","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmgm.2024.108939_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.730288","article-title":"Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach","volume":"11","author":"Kushwaha","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jmgm.2024.108939_bib39","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.3390\/molecules26123775","article-title":"Targeting 3CLpro and SARS-CoV-2 RdRp by amphimedon sp. metabolites: a computational study","volume":"26","author":"Shady","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2024.108939_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130488","article-title":"In search of RdRp and Mpro inhibitors against SARS CoV-2: molecular docking, molecular dynamic simulations and ADMET analysis","volume":"1239","author":"Gajjar","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2024.108939_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105468","article-title":"Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: a promising therapeutic approach for Tackling COVID-19","volume":"145","author":"Parihar","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2024.108939_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273256","article-title":"Potential SARS-CoV-2 RdRp inhibitors of cytidine derivatives: molecular docking, molecular dynamic simulations, ADMET, and POM analyses for the identification of pharmacophore sites","volume":"17","author":"Kawsar S","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2024.108939_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s43141-022-00339-y","article-title":"Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach","volume":"20","author":"Veerasamy","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.jmgm.2024.108939_bib44","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s11224-022-01999-9","article-title":"Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics","volume":"33","author":"Mohammed","year":"2022","journal-title":"Struct. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib45","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/07391102.2020.1822209","article-title":"A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp)","volume":"40","author":"Ribaudo","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2024.108939_bib46","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.12688\/f1000research.26359.1","article-title":"Targeting SARS-CoV-2 RNA-dependent RNA polymerase: an in silico drug repurposing for COVID-19","volume":"9","author":"Baby","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.jmgm.2024.108939_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pcmedi\/pbab001","article-title":"Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs","volume":"4","author":"Hosseini","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.jmgm.2024.108939_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100719","article-title":"Computational prediction of the potential target of SARS-CoV-2 inhibitor plitidepsin via molecular docking, dynamic simulations and MM-PBSA calculations","volume":"19","author":"El Hassab","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.jmgm.2024.108939_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/scipharm90020024","article-title":"Repurposing of four drugs as anti-SARS-CoV-2 agents and their interactions with protein targets","volume":"90","author":"Vesga","year":"2022","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.jmgm.2024.108939_bib50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/fmb-2022-0083","article-title":"Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective","volume":"17","author":"Elfiky","year":"2022","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jmgm.2024.108939_bib51","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jmgm.2024.108939_bib52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of \u03b3\u03b4 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jmgm.2024.108939_bib53","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1093\/nar\/gkab677","article-title":"NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain","volume":"49","author":"Wang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2024.108939_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jmgm.2024.108939_bib55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000508734","article-title":"Clinical characteristics of elderly patients with COVID-19 in hunan province, China: a multicenter, retrospective study","volume":"66","author":"Guo","year":"2020","journal-title":"Gerontology"},{"key":"10.1016\/j.jmgm.2024.108939_bib56","doi-asserted-by":"crossref","first-page":"11296","DOI":"10.18632\/aging.103535","article-title":"Clinical characteristics of older and younger patients infected with SARS-CoV-2","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jmgm.2024.108939_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41423-023-01098-7","article-title":"The interplay of drug therapeutics and immune responses to SARS-CoV-2","volume":"21","author":"Fumagalli","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jmgm.2024.108939_bib58","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkv352","article-title":"ChEMBL web services: streamlining access to drug discovery data and utilities","volume":"43","author":"Davies","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2024.108939_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pharmtox-061220-093932","article-title":"Structural basis of SARS-CoV-2- and SARS-CoV-receptor binding and small-molecule blockers as potential therapeutics","volume":"61","author":"Sivaraman","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jmgm.2024.108939_bib60","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib61","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2024.108939_bib62","series-title":"Proc. IBM Intern. Rep.","first-page":"1","article-title":"An elementary mathematical theory of classification and prediction","author":"Tanimoto","year":"1958"},{"key":"10.1016\/j.jmgm.2024.108939_bib63","doi-asserted-by":"crossref","first-page":"26792","DOI":"10.1039\/D0RA04743K","article-title":"Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2","volume":"10","author":"Koulgi","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2024.108939_bib64","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib65","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2024.108939_bib67","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nsb0902-646","article-title":"Molecular dynamics simulations of biomolecules","volume":"9","author":"Karplus","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jmgm.2024.108939_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1063\/1.447334","article-title":"A unified formulation of the constant temperature molecular dynamics methods","volume":"81","author":"Nos\u00e9","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2024.108939_bib69","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/00268979600100761","article-title":"Explicit reversible integrators for extended systems dynamics","volume":"87","author":"Martyna","year":"1996","journal-title":"Mol. Phys."},{"key":"10.1016\/j.jmgm.2024.108939_bib70","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.jmgm.2024.108939_bib71","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","article-title":"Bio3d: an R package for the comparative analysis of protein structures","volume":"22","author":"Grant","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2024.108939_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pro.3923","article-title":"The Bio3D packages for structural bioinformatics","volume":"30","author":"Grant","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2024.108939_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.105365","article-title":"Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling, molecular docking and molecular dynamics simulation","volume":"17","author":"Xu","year":"2024","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2024.102691","article-title":"Design, synthesis, and bioevaluation of novel unsaturated cyanoacetamide derivatives: in vitro and in silico exploration","volume":"12","author":"Uddin","year":"2024","journal-title":"MethodsX"},{"key":"10.1016\/j.jmgm.2024.108939_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202304929","article-title":"Investigating baxdrostat and its derivatives as aldosterone synthase inhibitors for resistant hypertension: an in silico approach","volume":"9","author":"Labiba","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jmgm.2024.108939_bib76","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with gromacs","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2024.108939_bib77","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py : an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2024.108939_bib78","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/jacs.6b02682","article-title":"Interaction entropy: a new paradigm for highly efficient and reliable computation of protein-ligand binding free energy","volume":"138","author":"Duan","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2024.108939_bib79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10822-016-9977-1","article-title":"Lessons learned from comparing molecular dynamics engines on the SAMPL5 dataset","volume":"31","author":"Shirts","year":"2017","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2024.108939_bib80","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1021\/acs.jctc.1c00374","article-title":"On the use of interaction entropy and related methods to estimate binding entropies","volume":"17","author":"Ekberg","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2024.108939_bib81","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2024.108939_bib82","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses","volume":"399","author":"Consortium","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2024.108939_bib83","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2024.108939_bib84","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jpha.2016.07.001","article-title":"Determination of pKa values of alendronate sodium in aqueous solution by piecewise linear regression based on acid-base potentiometric titration","volume":"6","author":"Ke","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jmgm.2024.108939_bib85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/minf.201100135","article-title":"Free energy calculations by the molecular mechanics Poisson\u2212Boltzmann surface area method","volume":"31","author":"Homeyer","year":"2012","journal-title":"Mol. Inform."},{"key":"10.1016\/j.jmgm.2024.108939_bib86","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jmb.2007.02.055","article-title":"Global changes in local protein dynamics reduce the entropic cost of carbohydrate binding in the arabinose-binding protein","volume":"368","author":"MacRaild","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2024.108939_bib87","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/phar.2429","article-title":"Remdesivir: review of pharmacology, pre\u2010clinical data, and emerging clinical experience for COVID\u201019","volume":"40","author":"Jorgensen","year":"2020","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.jmgm.2024.108939_bib88","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/B978-0-323-05876-6.00073-3","article-title":"Principles of drug therapy, dosing, and prescribing in chronic kidney disease and renal replacement therapy","author":"Cervelli","year":"2010","journal-title":"Compr. Clin. Nephrol."},{"key":"10.1016\/j.jmgm.2024.108939_bib89","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1210\/jc.2015-3467","article-title":"Preadmission bisphosphonate and mortality in critically ill patients","volume":"101","author":"Lee","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jmgm.2024.108939_bib90","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/jbmr.4030","article-title":"Nitrogen\u2010containing bisphosphonates are associated with reduced risk of pneumonia in patients with hip fracture","volume":"35","author":"Sing","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jmgm.2024.108939_bib94","doi-asserted-by":"crossref","first-page":"17738","DOI":"10.1038\/s41598-024-68356-0","article-title":"Clinical outcomes of COVID-19 infection in patients with osteoporosis: a nationwide cohort study in Korea using the common data model","volume":"14","author":"Ahn","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326324002390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326324002390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T01:35:34Z","timestamp":1740533734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326324002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":89,"alternative-id":["S1093326324002390"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2024.108939","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico evaluation of bisphosphonates identifies leading candidates for SARS-CoV-2 RdRp inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2024.108939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108939"}}